Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 6UYD | 6UYD | Structure of Hepatitis C Virus Envelope Glycoprotein E2mc3-v1 redesigned core from genotype 1a bound to broadly neutralizing antibody AR3C | |
| 6UUM | 6UUM | Crystal structure of antibody 438-B11 DSS mutant (Cys98A-Cys100aA) | |
| 6UUL | 6UUL | Crystal structure of broad and potent HIV-1 neutralizing antibody 438-D5 | |
| 6UUH | 6UUH | Crystal structure of broad and potent HIV-1 neutralizing antibody 438-B11 | |
| 6UUD | 6UUD | Crystal structure of antibody 5D5 in complex with PfCSP N-terminal peptide | |
| 6UTK | 6UTK | Crystal structure of 438-B11 Fab in complex with an uncleaved prefusion optimized (UFO) soluble BG505 trimer and Fab 35O22 at 3.80 Angstrom | |
| 6USF | 6USF | CryoEM structure of human alpha4beta2 nicotinic acetylcholine receptor with varenicline in complex with anti-BRIL synthetic antibody BAK5 | Neuronal acetylcholine receptor subunit alpha-4,Soluble cytochrome b562, Neuronal acetylcholine receptor subunit beta-2, Fab heavy chain, Fab light chain |
| 6URM | 6URM | Crystal structure of vaccine-elicited receptor-binding site targeting antibody LPAF-a.01 in complex with Hemagglutinin H1 A/California/04/2009 | |
| 6URH | 6URH | Crystal structure of broadly neutralizing antibody AR3X in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain | |
| 6UR5 | 6UR5 | Resurfaced influenza hemagglutinin in complex with a broadly neutralizing antibody | |
| 6UQR | 6UQR | Complex of IgE and Ligelizumab | |
| 6UM7 | 6UM7 | Cryo-EM structure of vaccine-elicited HIV-1 neutralizing antibody DH270.mu1 in complex with CH848 10.17DT Env | Envelope glycoprotein gp41, Envelope glycoprotein gp120, DH270.mu1 Fab Heavy Chain, DH270.mu1 Fab Light chain |
| 6UM6 | 6UM6 | Cryo-EM structure of HIV-1 neutralizing antibody DH270.6 in complex with CH848 10.17DT Env | Envelope glycoprotein gp120, DH270.6 Fab, Envelope glycoprotein gp41 |
| 6UM5 | 6UM5 | Cryo-EM structure of HIV-1 neutralizing antibody DH270 UCA3 in complex with CH848 10.17DT Env | Envelope glycoprotein gp41, Envelope glycoprotein gp120, DH270 UCA3 Fab heavy chain, DH270 UCA3 Fab light chain |
| 6ULC | 6ULC | Structure of full-length, fully glycosylated, non-modified HIV-1 gp160 bound to PG16 Fab at a nominal resolution of 4.6 Angstrom | Envelope glycoprotein GP120, Envelope glycoprotein GP41, Antibody PG16 Fab heavy chain, Antibody PG16 Fab light chain |
| 6ULC | 6ULC | Structure of full-length, fully glycosylated, non-modified HIV-1 gp160 bound to PG16 Fab at a nominal resolution of 4.6 Angstrom | Envelope glycoprotein GP120, Envelope glycoprotein GP41, Antibody PG16 Fab heavy chain, Antibody PG16 Fab light chain |
| 6UJF | 6UJF | Crystal structure of the Clostridial cellulose synthase subunit Z (CcsZ) from Clostridioides difficile | |
| 6UJC | 6UJC | Integrin alpha-v beta-8 in complex with the Fabs C6-RGD3 and 11D12v2 | Integrin alpha-V, Integrin beta-8, C6-RGD3 heavy chain Fab, C6-RGD3 light chain Fab |
| 6UJB | 6UJB | Integrin alpha-v beta-8 in complex with the Fabs C6D4 and 11D12v2 | Integrin alpha-V, Integrin beta-8, C6D4 heavy chain Fab, C6D4 light chain Fab |
| 6UIG | 6UIG | Crystal structure of human monoclonal antibody H7.200 in complex with H7N9 hemagglutinin HA1 | |
| 6UIB | 6UIB | Crystal structure of IL23 bound to peptide 23-652 | |
| 6UGY | 6UGY | Crystal structure of the Fc fragment of anti-TNFa antibody infliximab (Remicade) in a primative orthorhombic crystal form, Lot C | |
| 6UGY | 6UGY | Crystal structure of the Fc fragment of anti-TNFa antibody infliximab (Remicade) in a primative orthorhombic crystal form, Lot C | |
| 6UGX | 6UGX | Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a primative orthorhombic crystal form, Lot A | |
| 6UGX | 6UGX | Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a primative orthorhombic crystal form, Lot A | |
| 6UGW | 6UGW | Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered orthorhombic crystal form, Lot A | |
| 6UGW | 6UGW | Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered orthorhombic crystal form, Lot A | |
| 6UG9 | 6UG9 | Complex of ch28/11 Fab and SSEA-4 (hexagonal form) | |
| 6UG8 | 6UG8 | Complex of ch28/11 Fab and SSEA-4 (monoclinic form) | |
| 6UG7 | 6UG7 | Complex of ch28/11 Fab and SSEA-4 (tetragonal form) | |
| 6UDK | 6UDK | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
| 6UDK | 6UDK | HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 | RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41 |
| 6UDJ | 6UDJ | HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 | 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120 |
| 6UDJ | 6UDJ | HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 | 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120 |
| 6UDA | 6UDA | Cryo-EM structure of CH235UCA bound to Man5-enriched CH505.N279K.G458Y.SOSIP.664 | CH505.N279K.G458Y.SOSIP.664 gp120, CH235 UCA heavy chain Fab, CH505.N279K.G458Y.SOSIP.664 gp41, CH235 UCA light chain Fab |
| 6U7H | 6U7H | Cryo-EM structure of the HCoV-229E spike glycoprotein | spike glycoprotein |
| 6U7F | 6U7F | HCoV-229E RBD Class IV in complex with human APN | |
| 6U7E | 6U7E | HCoV-229E RBD Class III in complex with human APN | |
| 6U6U | 6U6U | IL36R extracellular domain in complex with BI655130 Fab | |
| 6U59 | 6U59 | HIV-1 B41 SOSIP.664 in complex with rabbit antibody 13B | SOSIP.664 gp120, SOSIP.664 gp41, rabbit antibody 13B Fragment antigen binding light chain, rabbit antibody 13B Fragment antigen binding heavy chain |
| 6U59 | 6U59 | HIV-1 B41 SOSIP.664 in complex with rabbit antibody 13B | SOSIP.664 gp120, SOSIP.664 gp41, rabbit antibody 13B Fragment antigen binding light chain, rabbit antibody 13B Fragment antigen binding heavy chain |
| 6U3O | 6U3O | JR51 DQ2-p.aeru-alpha2a complex | |
| 6U3N | 6U3N | LS2.8/3.15 - DQ2-P.fluor-alpha1a complex | |
| 6U3M | 6U3M | DQ2-P.fluor-alpha1a | HLA class II histocompatibility antigen, DQ alpha 1 chain, MHC class II HLA-DQ-beta-1 - DQ2-glia-omega1 chimeric protein |
| 6U0N | 6U0N | Asymmetrically open conformational state (Class II) of HIV-1 Env trimer BG505 SOSIP.664 in complex with sCD4 and E51 Fab | HIV-1 envelope glycoprotein gp120, T-cell surface glycoprotein CD4, E51 Fab heavy chain, E51 Fab light chain, HIV-1 envelope glycoprotein gp41 |
| 6U0L | 6U0L | Asymmetrically open conformational state (Class I) of HIV-1 Env trimer BG505 SOSIP.664 in complex with sCD4 and E51 Fab | |
| 6U02 | 6U02 | CryoEM-derived model of NA-63 Fab in complex with N9 Shanghai2 | Neuraminidase (E.C.3.2.1.18), NA-22 fragment antigen binding light chain, NA-22 fragment antigen binding heavy chain |
| 6TYS | 6TYS | A potent cross-neutralizing antibody targeting the fusion glycoprotein inhibits Nipah virus and Hendra virus infection | Fusion glycoprotein F0, 5B3 antibody heavy chain, 5B3 antibody light chain |
| 6TYS | 6TYS | A potent cross-neutralizing antibody targeting the fusion glycoprotein inhibits Nipah virus and Hendra virus infection | Fusion glycoprotein F0, 5B3 antibody heavy chain, 5B3 antibody light chain |
| 6TYB | 6TYB | Isolation and Structure of an Antibody that Fully Neutralizes Isolate SIVmac239 Reveals Functional Similarity of SIV and HIV Glycan Shields |
